SCHEMBL16035670

SCHEMBL16035670

Cn1ccc(-c2nccc(N)c2N)n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.46
▸ KDM4A O75164 1/20 0.46
▸ KDM4B O94953 1/20 0.46
▸ KDM5B Q9UGL1 1/20 0.46
▸ JMJD6 Q6NYC1 7/20 0.41
▸ KMT2A Q03164 1/20 0.40
▸ RET P07949 1/20 0.38
▸ ADORA2A P29274 4/20 0.37
▸ CYP19A1 P11511 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIP5K1C O60331 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PI4KA P42356 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ PI4KB Q9UBF8 1/20 0.35
▸ TGFBR1 P36897 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ MAP4K1 Q92918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19480884 0.84 KEAP1 (0.44) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL22230356 0.79 KEAP1 (0.50) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL30211937 0.79 KEAP1 (0.46) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL20912233 0.71 KDM4A (0.46) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL18448976 0.70 KDM4A (0.44) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL26966622 0.70 KDM4A (0.44) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL30509529 0.69 KMT2A (0.46) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL19480879 0.69 KEAP1 (0.43) KEAP1KDM4AKDM4BKDM5BJMJD6
SCHEMBL28469616 0.69 AXL (0.48) ADORA2APIM1MAP4K1
SCHEMBL18157906 0.68 KMT2A (0.64) KEAP1KDM4AKDM4BKDM5BJMJD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116930-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-04-11 — — US disclosed
US-11820770-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 — — US disclosed
US-20220213095-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-07-07 — — US disclosed
US-11225478-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2022-01-18 — — US disclosed
US-20200325138-A1 P2X7 Modulators JANSSEN PHARMACEUTICA NV (BE) 2020-10-15 — — US disclosed
US-10703749-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2020-07-07 — — US disclosed
US-20190092770-A1 P2X7 Modulators JANSSEN PHARMACEUTICA NV (BE) 2019-03-28 — — US disclosed
US-10150765-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2018-12-11 — — US disclosed
EP-3239151-B1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-11-07 — — EP disclosed
US-10112937-B2 P2X7 modulators and methods of use JANSSEN PHARMACEUTICA NV (BE) 2018-10-30 — — US disclosed
EP-2970267-B3 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-30 — — EP disclosed
EP-3239151-A1 P2X7 MODULATORS Janssen Pharmaceutica NV (BE) 2017-11-01 — — EP disclosed
EP-2970267-B1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-05-24 — — EP disclosed
US-20160376271-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV 2016-12-29 — — US disclosed
US-9464084-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2016-10-11 — — US disclosed
US-20160039809-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-02-11 — — US disclosed
US-20150322062-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-11-12 — — US disclosed
US-9066946-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2015-06-30 — — US disclosed
US-20140275015-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200325138-A1 P2X7 Modulators P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-10150765-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-20160376271-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-20190092770-A1 P2X7 Modulators P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-11225478-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-10112937-B2 P2X7 modulators and methods of use P2RX2, P2RX7, P2RX5 KEAP1 2190/4885KDM4A 3928/4885KDM4B 3026/4885
US-20160039809-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RX5 KEAP1 1458/4885KDM4A 4219/4885KDM4B 3478/4885
US-20150322062-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-11820770-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-20220213095-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-20240116930-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-10703749-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885
US-20140275015-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 KEAP1 1633/4885KDM4A 4249/4885KDM4B 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback